An analysis of pivotal phase 3 trials shows supplements to arrest age-related macular degeneration have no effect on ...

Discover which lifestyle moves, drops and other strategies give your eyes relief from screens, allergens, and life in general ...

LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on ...

ExSight Ventures, a venture capital firm dedicated to investing in transformative ophthalmology innovations, today announced its investment in RevOpsis Therapeutics, a biotechnology company pioneering ...

Belite Bio completes its phase 3 trial for tinlarebant, a potential first treatment for Stargardt disease, with results ...

Carrots offer significant health benefits, primarily from their rich content of beta-carotene, vitamin A, fiber, and ...

Investing in OCT at a national level will enhance patient outcomes, support clinical decision-making and ease the burden on ...

Researchers have discovered in a new study that patients with age-related eye diseases (AREDs) have a significantly increased ...

When most people think of global warming, they picture melting glaciers, intense heat waves, or rising seas. What is less ...

The integration of machine learning and artificial intelligence (AI) is providing a new lens for viewing retinal health, ...

The Company granted stock options to purchase up to an aggregate of 140,600 shares of EyePoint common stock to eight new employees. The stock options were granted on September 15, 2025. The grants ...